Osborne Clarke in Amsterdam advises iOnctura on extension Series A financing to €20.1M
Osborne Clarke in Amsterdam has advised iOnctura, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting...
Published on
15/07/2020
Read time
1m